0
Clinical Investigations: ASTHMA |

Effects of Inhaled Corticosteroid and Short Courses of Oral Corticosteroids on Bone Mineral Density in Asthmatic Patients*: A 4-Year Longitudinal Study

Hisako Matsumoto, MD; Kyosuke Ishihara, MD; Tsuyoshi Hasegawa, MD; Bun-ichi Umeda, MD; Akio Niimi, MD; Megumu Hino, MD
Author and Funding Information

*From the Department of Respiratory Diseases (Drs. Ishihara, Hasegawa, and Umeda) and Nuclear Medicine (Dr. Hino), Kobe City General Hospital, Kobe, Japan; and the Department of Respiratory Medicine (Drs. Matsumoto and Niimi), Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Correspondence to: Hisako Matsumoto, MD, Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan; e-mail: hmatsumo@kuhp.kyoto-u.ac.jp



Chest. 2001;120(5):1468-1473. doi:10.1378/chest.120.5.1468
Text Size: A A A
Published online

Background: It is not certain whether inhaled corticosteroid (ICS) therapy reduces bone mineral density (BMD) in asthmatic patients. In addition, the potential risk of osteoporosis associated with the rescue use of short courses of oral corticosteroids (SC-OCS) is unclear.

Objective: To evaluate the effect of inhaled beclomethasone dipropionate (BDP) and SC-OCS on BMD in asthmatic patients.

Design: A 4-year longitudinal study.

Method: Lumbar BMD was measured twice by dual-energy x-ray absorptiometry at a mean (± SD) interval of 4.2 ± 0.1 years in 35 asthmatic adults (15 men and 20 postmenopausal women; mean age at the second evaluation, 60.6 ± 11.5 years) who had been treated with BDP and SC-OCS.

Results: The average period of BDP treatment was 7.7 ± 2.2 years (range, 4.8 to 13.0 years) at the second evaluation. During the study period, the daily dose of BDP was 765 ± 389 μg (range, 100 to 1,730 μg), and the frequency of SC-OCS was 1.9 ± 2.7 courses per year (range, 0.0 to 8.9 courses per year). As a whole, lumbar BMD was unchanged during the course of the study, whereas the Z score (ie, the percentage of normal value predicted from age and sex) increased significantly. Changes in BMD and Z scores in patients receiving high doses of BDP (ie, > 1,000 μg/d; n = 9) were not significantly different from those of patients receiving lower doses (ie, ≤ 1,000 μg/d; n = 26). However, patients receiving frequent SC-OCS (ie, > 2.5 courses per year; n = 9) showed a significantly greater loss in BMD and Z score compared with those receiving sporadic courses (ie,≤ 2.5 courses per year; n = 26) (p = 0.002 and p = 0.035, respectively).

Conclusions: ICS therapy per se does not affect BMD, whereas frequent SC-OCS may do so.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543